Prakt. lékáren. 2006; 2(5): 225-226

Flunitrazepam, nitrazepam - ztráta nebo zisk?

PharmDr. Kamil Hrubý Ph.D
_

Článek shrnuje farmakologické charakteristiky dvou benzodiazepinových hypnotik – flunitrazepamu a nitrazepamu. Tato dvě léčiva přestala být v České republice dostupná pro léčebné použití. Dále jsou uvedeny základní léčebné alternativy těchto látek a jejich dostupnost v USA, Velké Británii a Německu.

Keywords: Klíčová slova: flunitrazepam, nitrazepam.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubý K. Flunitrazepam, nitrazepam - ztráta nebo zisk? Praktické lékárenství. 2006;2(5):225-226.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Flunitrazepam. In: The Merck Index 1996. Merck & Co., Inc. 1996. 702 s.
    2. Nitrazepam. In: The Merck Index 1996. Merck & Co., Inc. 1996. 1129 s.
    3. Flunitrazepam. In: Martingale: the complete drug reference. Pharmaceutical Press 1999. 670 s.
    4. Flunitrazepam. In: Martingale: the complete drug reference. Pharmaceutical Press 1999. 682 s.
    5. Mogadon(R). In: Compendium of Pharmaceuticals and Specialties. Canadian Pharmaceutical Association 1997: 962-963.
    6. Rohypnol, Nitrazepam Slovakofarma. In: Mikro-verze AISLP - ČR 2005.
    7. Kangas L. Urinary elimination of nitrazepam and its main metabolites. Acta Pharmacol Toxicol (Copenh) 1979; 45: 16-19. Go to original source... Go to PubMed...
    8. Luurila H et al. Interaction between erythromycin and nitrazepam in healthy volunteers. Pharmacol Toxicol 1995; 76: 255-258. Go to original source... Go to PubMed...
    9. Penq FC et al. NADPH-cytochrome P-450 reductase is involved in flunitrazepam reductive metabolism in Hep G2 and Hep 3B cells. J Toxicol Environ Health A 2004; 67: 109-124. Go to original source... Go to PubMed...
    10. Gafni I et al. The role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo. J Clin Psychopharmacol 2003; 23: 169-175. Go to original source... Go to PubMed...
    11. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18: 297-328. Go to original source... Go to PubMed...
    12. Simmons MM et al. Use and abuse of flunitrazepam. Ann Pharmacother 1998; 32: 117-119. Go to original source... Go to PubMed...
    13. http://cs.wikipedia.org/wiki/Rohypnol
    14. Curtis JL et al. Sleep Disorders. In: Pharmacotherapy: A Pathophysiologic Approach, Fifth Edition. McGraw-Hill Companies, Inc. 2002: 1323-1334.
    15. Electronic Orange Book. www.fda.gov
    16. www.rote-liste.de
    17. www.bnf.org

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.